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Abstract
Background: The msaABCR operon regulates several staphylococcal phenotypes such as biofilm formation, capsule
production, protease production, pigmentation, antibiotic resistance, and persister cells formation. The msaABCR operon is
required for maintaining the cell wall integrity via affecting peptidoglycan cross-linking. The msaABCR operon also plays a
role in oxidative stress defense mechanism, which is required to facilitate persistent and recurrent staphylococcal infections.
Staphylococcus aureus is the most frequent cause of chronic implant-associated osteomyelitis (OM). The CA-MRSA USA300
strains are predominant in the United States and cause severe infections, including bone and joint infections.
Results: The USA300 LAC strain caused significant bone damage, as evidenced by the presence of severe bone
necrosis with multiple foci of sequestra and large numbers of multinucleated osteoclasts. Intraosseous survival and
biofilm formation on the K-wires by USA300 LAC strains was pronounced. However, the msaABCR deletion mutant was
attenuated. We observed minimal bone necrosis, with no evidence of intramedullary abscess and/or fibrosis, along
reduced intraosseous bacterial population and significantly less biofilm formation on the K-wires by the msaABCR
mutant. microCT analysis of infected bone showed significant bone loss and damage in the USA300 LAC and
complemented strain, whereas the msaABCR mutant’s effect was reduced. In addition, we observed increased
osteoblasts response and new bone formation around the K-wires in the bone infected by the msaABCR mutant.
Whole-cell proteomics analysis of msaABCR mutant cells showed significant downregulation of proteins, cell adhesion
factors, and virulence factors that interact with osteoblasts and are associated with chronic OM caused by S. aureus.
Conclusion: This study showed that deletion of msaABCR operon in USA300 LAC strain lead to defective biofilm in Kwire implants, decreased intraosseous survival, and reduced cortical bone destruction. Thus, msaABCR plays a role in
implant-associated chronic osteomyelitis by regulating extracellular proteases, cell adhesions factors and virulence
factors. However additional studies are required to further define the contribution of msaABCR-regulated molecules in
osteomyelitis pathogenesis.
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Background
Staphylococcus aureus is the most common pathogen causing chronic infections in humans [1–3], and osteomyelitis
(OM) is one of the primary chronic infections caused by
this pathogen [4–7]. According to Gerber et al. [2] and
Weichert et al. [8], approximately 2.5 of every 1000 hospital
admitted children has staphylococcal OM [2, 8]. Among
adults, staphylococcal OM frequently complicates open
fractures and soft-tissue infections [6, 9]. In addition, nosocomial infections by S. aureus in immunocompromised patients, severely debilitated patients, and patients with
indwelling medical devices are on the rise [10–12]. The increasing use of surgically implanted orthopedic medical devices has led to an increased risk of implant-associated OM
infection [6, 13, 14]. Implant-associated OM is a chronic
and deep bone infection, and studies have shown that S.
aureus is the most common causative pathogen, accounting
for 20–30% of chronic OM cases associated with fracture
fixation and prosthetic joint replacement [15–18]. According to Darouiche [19], 600, 000 artificial joint replacements
and 2 million fracture fixation devices are implanted each
year in the U.S., resulting in > 110,000 infections [19]. Furthermore, 65% of military injuries are orthopedic, with an
infection rate of 50%, and S. aureus is the most prevalent
pathogen in these infections [19]. The communityassociated, methicillin-resistant S. aureus (CA-MRSA)
strains are emerging as leading pathogens causing the severe sepsis associated with acute OM [5, 7, 8, 20]. The CAMRSA USA300 clone is the predominant strain in the
United States and has been responsible for severe infections, including bone and joint infections [21–24].
Treatment of OM infections by S. aureus is complex and
involves one or more surgical debridement, implant
removal, and prolonged antimicrobial therapy. The ability
of S. aureus to form biofilm, small colony variants, and
persister cells inside osteoblasts contributes to treatment
recalcitrance [25–28]. Previous retrospective studies by
Marculescu et al. [29] and Lee et al. [30] both found that
the treatment failure rate for implant-associated OM is high
(58.2 and 41.8%, respectively). Thus, despite all the sophisticated procedures and efforts to maintain high sterility standards to prevent onset of implant-associated OM infection,
it is still a significant challenge in the clinic [11, 12].
The msaABCR operon is a four-gene operon that regulates several virulence factors (proteases as well as factors involved in pigmentation, toxin production, and
capsule production), biofilm formation, persister cell formation, oxidative stress response, and antibiotic susceptibility in S. aureus [31–37]. We also showed that
msaABCR deletion mutants are not defective in growth
[33]. Previously, we showed that msaABCR mutants are
defective in biofilm formation due to increased production of extracellular proteases in vitro [31]. MsaB is the
only protein expressed from this operon, and we have
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shown that MsaB is the DNA-binding protein that directly
regulates the virulence factor for processes such as capsule
production [32, 34, 35]. A separate study by Caballero et al.
[38] showed that MsaB is an RNA chaperone that positively
and negatively modulates the expression of its target proteins, which are involved in carbohydrate metabolism, ribonucleotide metabolism, and the stress response, and these
include several other virulence factors [38]. Previously, we
also showed that the msaABCR operon regulates the expression of 238 genes that are involved in metabolism,
pathogenesis, transport, signal transduction, and stress
response [33]. The primary objective of this study is to test
the contribution of the global modulator msaABCR operon
in pathogenesis in vivo using implant-associated OM in a
SD rat model. In this model of implant associated osteomyelitis, we used K-wires coated with S. aureus strains to
implant transcortically through the tibial metaphysis as previously described to mimic clinical OM infection [39, 40].
We used community-associated methicillin-resistant S. aureus strain USA300 LAC and its isogenic msaABCR mutant.

Results
The chronic implant-associated OM model

Sprague Dawley rats were used to study the role of the
msaABCR operon in the pathogenesis of chronic implantassociated OM and intraosseous bacterial survival. Rats
were infected with a clinical isolate of USA300 LAC due to
its prevalence in community-associated invasive infections.
For induction of chronic implant-associated OM, K-wires
were first colonized with the test strains (USA300 LAC,
msaABCR mutant, and msaABCR complementation) and
implanted transcortically through the bone metaphysis
(Fig. 1a). To ensure that the bacterial cells attach the Kwires at the same rate, the bacterial CFUs were enumerated
from the colonized K-wires (six K-wires per bacterial
strain). The average number of bacterial CFUs colonized in
the K-wires (1.25X107 CFUs) was similar in all test strains
and were not statistically different (Fig. 1b). Also, to ensure
an equivalent number of bacterial inoculums in the bone
prior to infection process and during surgery, the infected
K-wires with test strains (3 animals per group) were
inserted in the rat bone. The rats were humanely euthanized immediately to harvest the bone and K-wire samples
to enumerate the bacterial CFUs. The average bacterial load
retained in the bone (6.09X105 CFUs) and on the K-wires
(1.45X104 CFUs) after the surgical procedure were not statistically different from each other (Fig. 1b).
Intraosseous bacterial burden and biofilm formation

The intraosseous bacterial burden in the infected bone
was assessed after each infection period as described in
the methods (Fig. 2a, b, and c). The K-wires were carefully
excised from the infected bone samples and processed for
microbial counting to quantify biofilm formation in the K-

Sahukhal et al. BMC Microbiology

(2020) 20:324

Page 3 of 20

Fig. 1 Examination of K-wire localization and microbial load in bone and K-wires after surgery. The K-wire was inserted in the tibia of Sprague
Dawley rats surgically and examined by X-ray to assure its positioning (a). The microbial load before K-wire implantation and after surgery (b). The
microbial load was estimated for both K-wires and bone (n = 3) to ensure an equal starting microbial load (USA300 LAC, msaABCR mutant, and
complementation strains) prior to the infection process. Error bars indicate standard errors of the means. The differences in the numbers of
microbial CFUs between the test strains were not statistically significant when analyzed by one-way ANOVA followed a post-hoc Tukey test

wires (Fig. 2d, e, and f). The results showed that the
intraosseous bacterial burden in the infected bone and biofilm formation in the k-wires were significantly less in the
msaABCR mutant group compared to the USA300 LAC
and the complementation group during all post-infection
periods (Fig. 2). These findings showed that the msaABCR
mutant is defective in intraosseous survival and biofilm formation on K-wires in the implant-associated OM rat model
(Fig. 2). These observations correlate with our previous
findings showing a defective biofilm phenotype for the
msaABCR mutant under in vitro conditions [31].
Dissemination of Staphylococcus to different organs

To study bacterial survival in blood and dissemination to
different vital organs (heart, liver, spleen, lungs, kidney,
and liver), microbial counts were obtained from the postmortem blood and organ samples. Our results showed
that the bacterial CFUs in blood, heart, and spleen samples recovered from the animals infected with the
msaABCR mutant were less compared to USA300 LAC
and complementation strains during all post-infection periods, but the differences were not statistically significant
(Fig. 3a, b, and c). However, in the liver, kidney, and lung
samples, all the animals infected with all three test strains

showed similar numbers of bacterial CFUs throughout the
infection periods (Additional file 1: Fig. S1).
Analysis of bone damage by microCT

To further delineate the role of the msaABCR operon in
the pathogenesis of OM, the infected bones harvested
after each infection period were analyzed by microCT.
At day 4 post-infection, no significant bone damage was
observed in the reconstructed 3D microCT images of infected bone by all the test strains (Fig. 4a and b). However,
we observed significant cortical bone damage around the
K-wire insertion area in bone infected with the USA300
LAC and complementation strains after 8- and 15- days
post-infection periods relative to the bone infected with
the msaABCR mutant strains (Fig. 4c-f). During the
process of harvesting K-wires before microCT scanning of
the msaABCR mutant infected bone (Day 8), a small piece
of bone was missing near the infection area, as evident in
the 3D image (Fig. 4c). Morphometric analysis showed no
significant changes in bone microarchitectural patterns in
the infected bones by all test strains after 4- and 8- days
post-infection (Additional file 2: Fig. S2 and Additional file 3: Fig. S3). However, the significant changes the
bone microarchitectural patterns in the bone infected with
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Fig. 2 Microbial count from bone and K-wires samples. Microbial enumeration from post-mortem bone samples (a-c) and K-wire samples (n = 5)
were obtained to determine intraosseous bacterial survivability and biofilm formation on the K-wires (d-f) on days 4, 8, and 15 post-infection (left
to right). The infected bone sample and K-wires were harvested after each infection period (days 4, 8, and 15). Error bars indicate standard errors
of the means. The bacterial CFUs difference between the USA300 LAC and msaABCR mutant strains was analyzed using one-way ANOVA
followed by a post-hoc Tukey test. A P-value of < 0.05 was considered statistically significant (*p-value < 0.05, **p-value < 0.01, and
***p-value < 0.001)

the USA300 LAC and complementation strains were evident after 15 days post-infection. We observed significantly
altered BV/TV, BS/BV, Tb.pf, Tb. Sp, Tb. Th, and Tb. N in
the bone samples infected with the USA300 LAC and
complementation strains, thus revealing compromised
trabecular microarchitecture and massive bone destruction by these strains relative to the msaABCR mutant
strains (Fig. 5).
Histopathological analysis of infected bone

The infected bone samples were fixed, sectioned, and
stained with H&E, and histopathological scores were
assessed [41] , as shown in Table 1.
Day 4 post-infection

Bone samples from the sham group showed a minimal
presence of intraosseous inflammatory cells and intraosseous fibrosis, with no evidence of any periosteal abscess or
bone necrosis (Fig. 6a). Bone infected with the USA300
LAC strain showed severe intraosseous inflammation and
evidence of intramedullary abscess. We also observed the
presence of osteoclast activity in bone infected with
USA300 LAC strain (Fig. 6a). Bone infected by the
msaABCR mutant showed a minimal-to-mild intraosseous
inflammatory response with intramedullary abscess (Fig. 6a).
Bone infected with complementation strain showed severe

intraosseous inflammation and evidence of intramedullary
abscess (Fig. 6a). Overall, bone harvested from the sham
group received a total histopathological score of 2, whereas
bone infected by USA300 LAC, msaABCR mutant, and
complementation strains received total histopathological
scores of 8, 7, and 8, respectively (Fig. 6b).
Day 8 post-infection

We observed increased osteoblast response, with a minimal presence of intraosseous inflammatory cells, and with
no evidence of intramedullary abscess, intraosseous fibrosis, periosteal abscess, and bone necrosis in the bone infected with sham group (Fig. 7a). The presence of
moderate-to-severe intraosseous and periosteum inflammation with evidence of intramedullary abscess as well as
bone necrosis with multiple foci of sequestra are the hallmark features of bone infected with the USA300 LAC and
complementation strains (Fig. 7a). An increased osteoblast
response lining the site adjacent to the K-wire was also
observed in the bone infected with the msaABCR mutant,
but not observed in the bones infected with USA300 LAC
and complementation strains (Fig. 7a). However, we did
observe moderate-to-severe intraosseous inflammation,
minimal-to-mild intraosseous fibrosis and a moderate-tosevere inflammation without any evidence of intramedullary abscess and periosteal abscess in the bone infected
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Fig. 3 Microbial count from blood, heart, and spleen samples (left to right). The infected blood (a), heart (b), and spleen (c) samples were
processed to enumerate the bacterial CFUs, as described in methods, after each infection period (on days 4, 8, and 15). Error bars indicate
standard errors of the means. The difference in microbial counts between the USA300 LAC and msaABCR mutant strains was analyzed using oneway ANOVA followed by a post-hoc Tukey test. A P-value of < 0.05 was considered statistically significant

with msaABCR mutant (Fig. 7a). Bone necrosis with multiple foci without any sequestrum was observed in bone infected with the msaABCR mutant (Fig. 7a). In addition, we
also observed traces of bacteria in the bones infected by
each of the test strains, which was not evident in the bones
infected on days 4 and 15. Overall, on day 8 after infection,
the sham bone and bones infected with USA300
LAC, msaABCR mutant, and complementation strains
received histopathological scores of 1, 13, 8, and 11,
respectively (Fig. 7b).
Day 15 post-infection

Histopathological analysis of bone infected with sham
group after day 15 showed an active bone healing
process, with no evidence of bone necrosis or acute and
chronic intraosseous and periosteal inflammation
(Fig. 8a). The hallmark feature of bone infected with the
USA300 LAC strain is the presence of large multinucleated osteoclasts and severe bone necrosis with multiple
foci of sequestra formation (Fig. 8a). Moreover, we also
observed severe chronic intraosseous inflammation,
intramedullary abscess, and fibrosis with subperiosteal

abscess formation in the USA300 LAC infected bone
sample (Fig. 8a). Bone infected with msaABCR mutant
showed mild intraosseous and periosteal inflammation.
However, subperiosteal abscess, intramedullary abscess
and fibrosis were not observed in the bone infected
with msaABCR mutant. Although, a single focus of
bone necrosis without any sequestrum formation was
observed, active chondrocyte activity with newly
formed bones were also observed in the msaABCR
infected bone (Fig. 8a). Bone infected with the complementation strain also showed severe intraosseous
inflammation with intramedullary abscess, mild
chronic inflammation with significant intramedullary
fibrosis, and severe chronic inflammation without any
subperiosteal abscess formation (Fig. 8a). Severe bone
necrosis with a single focus of sequestrum was also
observed in the complementation strain infected bone
(Fig. 8a). Overall, sham bone received a total histopathological score of 0, whereas, USA300 LAC,
msaABCR mutant, and complementation strains received total scores of 16, 5, and 12 respectively
(Fig. 8b).
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Fig. 4 Reconstructed 3D microCT images of bone samples (sham and infected) and cortical bone destruction analysis. The sham and infected
bone samples were harvested after each infection period (on days 4, 8, and 15). The 3D microCT images of sham and infected bone samples (a,
c, and e) and cortical bone destruction analysis of sham and infected bones samples (b, d, and f). Reconstructed 3D images showed significant
bone damage and/or loss by USA300 LAC and complementation strains, which was also revealed by cortical bone destruction analysis. Bone
destruction analysis was subjected to one-way ANOVA followed by a post-hoc Tukey test. Error bars indicate standard errors of the means. A Pvalue of < 0.05 was considered statistically significant (**p-value < 0.01, and ***p-value < 0.001)

Host immunological response against staphylococcal
infection

The msaABCR mutant group showed increased ALP
activity

In this study we focused on three main pro-inflammatory
cytokines (IL-1, IL-6, and IL-17) that have been previously
linked to staphylococcal OM infections. We observed a significant decrease in IL-1 serum levels in animals infected
with msaABCR mutant relative to USA300 LAC and complementation strains after day 4 and day 8 post-infection.
However, after day 15 post-infection, IL-1 serum levels in
the animals infected with USA300 LAC strain was significantly less compared to the animals infected with
msaABCR mutant, complementation strains, and the animals that received sham K-wires (Fig. 9a). At this moment
we have no clear picture about reduced IL-1 levels in the
blood samples infected with USA300 LAC strains after day
15 post-infection. We did not observe any significant differences in the IL-6 serum levels in all test strains during all
post-infection periods (Fig. 9b). However, the IL-6 response
in the sham group was significantly higher than in all three
test groups (Fig. 9b). The animals infected with msaABCR
mutant showed significant increase in IL-17 levels relative
to the animals infected with the USA300 LAC and complementation strains during all post-infection periods (Fig. 9c).

In this study, we measured ALP from the post-mortem
blood samples as a marker of bone reformation. Our results showed significant increase in ALP activity in the
animals infected with the msaABCR mutant relative to
the animal group infected with USA300 LAC and complementation strains on day 4 and day 15 post-infection
(Fig. 10). However, on day 8 post-infection, we observed
no statistically significant difference in ALP activity between the test strains (Fig. 10).
The msaABCR proteome suggests defects in proteins
important for staphylococcal OM

Previously, we showed that deletion of the msaABCR operon affected the expression of 238 genes that play roles
in metabolism, virulence, and biofilm development.
msaABCR transcriptomics also showed that several
genes and operons that play roles in pathogenesis (fnbA,
lukF-PV, lukS-PV, sarA, the splABCDEF operon, and the
sspABC operon) were affected [33]. In previous studies
these genes and operons have been implicated in
staphylococcal OM. In this study whole-cell proteomics
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Fig. 5 Structural indices of sham and infected bones after day 15 post-infection. Analysis of trabecular bone microarchitecture (percentage bone
volume, BV/TV; bone surface/volume ratio, BS/BV; trabecular pattern factor, Tb.Pf; trabecular thickness, Tb.Th; trabecular spacing, Tb.Sp; and
trabecular number, Tb.N) were performed. All values were analyzed using one-way ANOVA followed by a post-hoc Tukey test. Error bars indicate
standard errors of the means. A P-value of < 0.05 was considered statistically significant (**p-value < 0.01)

of the msaABCR mutant was performed and compared
with the USA300 LAC strain under planktonic and biofilm
growth conditions. Whole-cell proteomics of the msaABCR
mutant under planktonic growth conditions revealed that a
total of 187 proteins were differentially expressed relative to
the USA300 LAC strain (Additional file 3: Table S1),
whereas under biofilm conditions 170 proteins were differentially expressed (Additional file 4: Table S2).
Deletion of the msaABCR operon led to decreased
expression of cell adhesion factors, virulence factors,
proteases, and immunomodulators that are important for
colonizing bone, interacting with osteoblasts / osteoclasts,
modulates secreted virulence factors and evade host
immune system (Table 2). Under planktonic growth conditions, msaABCR proteomes showed reduced production of
cell adhesion factors such as Fibronectin binding protein A
(FnbA), clumping factor A (ClfA), clumping factor B
(ClfB), serine–aspartate repeat-containing protein D
(SdrD), and Extracellular matrix binding protein (Embp),
but showed increased production of serine–aspartate
repeat-containing protein C (SdrC) (Table 2). Under biofilm growth conditions, only clumping factor A (clfA) was
significantly downregulated, whereas fibronectin-binding
protein A (FnbA), fibronectin-binding protein B (FnbB),
serine–aspartate repeat-containing protein C (SdrC),
serine–aspartate repeat-containing protein D (SdrD), and

Extracellular matrix binding protein (Embp) were upregulated (Table 2).
Staphylococcal virulence factors such as alphahemolysin (Hla) and uncharacterized leucocidin-like protein 1 (LukL1), which leads to osteoblast death or triggers
osteoclastogenesis and promotes persistence of infection,
were downregulated significantly in the msaABCR mutant
under planktonic conditions (Table 2). Under biofilm
growth condition staphylococcal protein A (SpA) was
downregulated (Table 2). Extracellular proteases, such as
aureolysin, serine proteases, cysteine proteases, and thermonucleases, are produced at a significantly higher level
by the msaABCR mutant in planktonic growth conditions.
However, under biofilm growth conditions extracellular
proteases such as cysteine protease and staphopain A are
produced at a significantly higher level (Table 2).
Staphylococcal immune modulator that has been previously studied to interfere with T-cell mediated host immune system, MAP protein, was undetectable in
msaABCR proteomics under both planktonic and biofilm
growth condition (Table 2). Staphylococcal immune evasion factor, Immunoglobulin-binding protein (Sbi), was
significantly downregulated under planktonic growth condition (Table 2). In addition, several proteins that play
roles in metabolism, DNA replication, transcription and
translation, transport systems, and pathogenesis were also
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Table 1 Histopathological parameters and scoring system to
evaluate bone damage as previously described by Smeltzer et
al. [41]
Histopathological parameters and scoring
Intraosseous acute inflammation (IAI):
0 Not present
1 Minimal-to-mild inflammation with no intramedullary abscess
2 Moderate-to-severe inflammation with no intramedullary abscess
3 Minimal-to-mild inflammation with intramedullary abscess
4 Moderate-to-severe inflammation with intramedullary abscess
Intraosseous chronic inflammation (ICI):
0 Not present
1 Minimal-to-mild chronic inflammation with no significant
intramedullary fibrosis
2 Moderate-to-severe chronic inflammation with no significant
intramedullary fibrosis
3 Minimal-to-mild chronic inflammation with significant
intramedullary fibrosis
4 Moderate-to-severe chronic inflammation with significant
intramedullary fibrosis
Periosteal inflammation (PI):
0 Not present
1 Minimal-to-mild inflammation with no subperiosteal abscess
formation
2 Moderate-to-severe inflammation with no subperiosteal abscess
formation
3 Minimal-to-mild inflammation with subperiosteal abscess formation
4 Moderate-to-severe inflammation with subperiosteal abscess
formation
Bone necrosis (BN):
0 No evidence of necrosis
1 Single focus of necrosis without sequestrum formation
2 Multiple foci of necrosis without sequestrum formation
3 Single focus of sequestrum
4 Multiple foci of sequestra

affected (Additional file 4: Tables S1 and Additional file 5:
Table S2).

Discussion
Community-associated MRSA USA300 LAC strain is
causing increasing numbers of OM cases in the US, with
approximately 100,000 new cases every year [7, 22, 23, 58].
When OM infections are associated with implants and
biofilm, they are very difficult to treat and often lead to
life-threatening complications such as septicemia, venous
thrombosis, and other pathologic fracture conditions [59–
61]. During recent years the common use of implant devices in all surgical fields has caused a drastic increase in
the number of implants and a higher risk of implantassociated infections. In this study we applied a similar
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surgical procedure to study implant-associated biofilm
OM models using a rat model as previously described that
closely mimic the clinical OM infections [39, 40]. We evaluated end-point quantification of viable cells from K-wires
and infected bone samples using clinical isolates of CAMRSA strain USA300 LAC, msaABCR mutant, and
msaABCR complementation strains. We showed that biofilm formation on the inserted K-wire implant and the
number of intraosseous bacterial CFUs in the bone samples were significantly reduced in animals infected with
the msaABCR mutant compared with animals infected
with the USA300 LAC and complementation strains during all post-infection periods. We also showed that the extent of bone damage and/or loss in the msaABCR mutant
infected bone was significantly reduced accompanied by
increased osteoblast response and evidenced the reactive
bone formation. Whereas, USA300 LAC and complementation strains showed significant bone damage and/or loss,
accompanied by massive osteoclast activation, severe bone
necrosis with multiple foci of sequestra formation, and
with chronic intramedullary abscess and intramedullary fibrosis. Therefore, this study showed that the infection of
bone with USA300 LAC strains resulted in an imbalance
of activity between osteoclast and osteoblast activity and
triggered massive bone damage, whereas the impact was
minimal when msaABCR operon was mutated. Thus, we
conclude that the msaABCR operon indeed plays a role in
implant-associated OM infection in a rat model.
Previous studies have shown the role of proinflammatory cytokines and chemokines in maintaining the balance between bone resorption and formation by
recruiting and activating infiltrated immune cells during
bacterial infection of bone [62–66]. Host cytokines such
as IL-1, IL-6, and IL-17 are important markers of bone
metabolism under pathological conditions [63, 65, 66].
IL-1 is a potent cytokine that is involved in bone resorption by inducing osteoclast differentiation at inflammatory sites during bone infection [62, 63]. The response of
the TH 17-associated cytokines IL-6 and IL-17 has been
shown to play an important role in bacterial infection in
human S. aureus-associated OM and in animal models
[64, 65, 67]. IL-17A promotes bone formation by stimulating osteoblastic proliferation and differentiation,
which facilitates bone fracture healing [65]. Another
study has shown that an increased IL-6 response activates osteoclast differentiation, thereby stimulating increased bone resorption activity in an osteoblast cell
culture model [64]. In this study, we showed that infection with USA300 LAC triggers IL-1 production but represses IL-17 production, thus leading to increased
osteoclast activity. Whereas the msaABCR mutant infected animals showed reduced IL-1 level and increased
IL-17 level, thus supporting increased osteoblast response, and reactive bone formation as demonstrated by
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Fig. 6 Hematoxylin and eosin (H&E) stained sections of representative bone samples after day 4 post-infection. Bone infected with sham (control)
pins or with the USA300 LAC (wild type), msaABCR mutant, or complementation strains (a) at low (left) and high (right) magnification. Blue arrows
show the points of insertion of K-wires, green arrows show osteoblast cells, and red arrows show osteoclasts cells. Total histopathological score of
infected bone (b). Histopathological scores were assessed on the basis of intraosseous acute inflammation (IAI, blue), intraosseous chronic
inflammation (ICI, orange), periosteal inflammation (PI, green), and bone necrosis (BN, yellow)

microCT and histopatholgical analysis of infected bone.
While we have not tested other host factors that trigger
bone degradation and/or formation in response to S.
aureus infection, our result showed that msaABCR mutant is defective in stimulating the host immune response to trigger osteoclast activation, which mediates
bone degradation. We also observed significantly reduced IL-1 serum levels in the animals infected with
USA300 LAC strain compared to the animals infected
with msaABCR mutant, complementation strains, and
the animals that received sham K-wires at day 15 postinfection. This is in contrast with histopathological data
that showed large multinucleated osteoclasts activity and
severe bone necrosis in the USA300 LAC infected bone
relative to msaABCR mutant infected bone. At this

moment we have no clear picture about reduced IL-1
levels in the blood samples infected with USA300 LAC
strains after day 15 post-infection. In addition, we also
observed increased IL-6 response in sham group compared to all test group. This result is in contrast with
previous result [64] that showed an increased IL-6 response in both human and mouse osteoblasts when infected with S. aureus; however, this difference might be
due to a difference in serum level response (this study)
versus the osteoblast local response in the previous
study.
Bone-specific ALP is synthesized by osteoblasts in response to bone injury and plays a role in bone matrix
calcification [67]. In studies on long bone fracture healing, alkaline phosphatase was shown to correlate with
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Fig. 7 Hematoxylin and eosin (H&E) stained sections of representative bone samples after day 8 post-infection. Bone infected with sham (control)
pins or with the USA300 LAC, msaABCR mutant, or complementation strains (a) at low (left) and high (right) magnification. Blue arrows show the
points of insertion of K-wires, green arrows show osteoblast cells, red arrows show osteoclasts cells, black arrows show bacterial cells, and yellow
arrows show newly formed bones. Total histopathological score of infected bone (b). Histopathological scores were assessed on the basis of
intraosseous acute inflammation (IAI, blue), intraosseous chronic inflammation (ICI, orange), periosteal inflammation (PI, green), and bone necrosis
(BN, yellow)

fracture callus volume, bone formation, and fracturehealing rates [68–70]. We observed significantly increased ALP activity in the animals infected with
msaABCR mutant. This observation correlates with the
microCT data and bone histopathological data concerning the infected bone, in which the animals that received
a sham pin and those infected with the msaABCR mutant showed increase osteoblast response during all
post-infection periods and evidence of newly formed
bones after day 15 post-infection. Whereas the reduced
ALP activity in animals infected with the wild type and
complementation strains may be the result of increase
osteoclast and less osteoblast activity, increased bone

loss, and with no evidence of any reactive bone formation even after 15 days post-infection.
Several studies showed that specific staphylococcal
proteins (MSCRAMMS and virulence factors) play a role
during the initial interaction with bone and the progression of OM infection [12, 42, 43, 47, 49, 50, 67, 71–73].
Bone extracellular matrix and bone cells are important
targets for microbes, especially Staphylococci, once the
bone is exposed to the external environment [6, 12, 74].
In a situation in which medical implants or K-wires are
inserted into the bone, the tissue–implant surface can be
a substrate for the attachment of the host extracellular
matrix proteins fibronectin, fibrinogen, albumin,
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Fig. 8 Hematoxylin and eosin (H&E) stained sections of representative bone samples after day 15 post-infection. Bone infected with sham pins
(control) or with the USA300 LAC, msaABCR mutant, or complementation strains (a) at low (left) and high (right) magnification. Blue arrows show
the points of insertion of the K-wires, green arrows show osteoblast cells, red arrows show osteoclasts cells, yellow arrows show newly formed
bones, and orange arrows show bone necrosis. Total histopathological scores of infected bone (b). Histopathological scores were assessed on the
basis of intraosseous acute inflammation (IAI, blue), intraosseous chronic inflammation (ICI, orange), periosteal inflammation (PI, green), and bone
necrosis (BN, yellow)

vitronectin, and collagen. The host matrix proteincoated K-wires provide a niche for the attachment of
hosts cells, such as fibroblasts, osteoblasts, and endothelial cells, but also facilitate the attachment of bacteria
such as S. aureus, thus promoting bacterial colonization
and biofilm formation [12, 44, 75–79]. Studies have
shown that staphylococcal clones that possess cna, bbp,
and/or fnbB genes are efficient in attaching to bone
extracellular matrix and concentrating around the osteoblasts. Of all the S. aureus strains that cause OM, 10–
60% express cna, bbp, and fnbB, whereas all S. aureus
strains express either fnbA or clumping factors A and B
[57, 80, 81]. S. aureus also produces several virulence

factors that can directly interact with osteoblasts and
bone extracellular matrix, thus triggering increased ostecloclastogenesis and causing serious bone damage in the
host [12, 20, 21, 42, 47–50, 61, 67, 71–74, 77]. Crémieux
et al. [48] showed that Panton-Valentine leucocidin
(PVL), produced by CA-MRSA strains, induces increased bone deformation and muscular abscess in an
OM study in a rabbit model. In addition, CA-MRSA
strains of S. aureus also overexpress several other virulence factors, such as α-hemolysin (Hla), phenol-soluble
modulin (psms), and proteases, which are critical virulence factors in several animal models for brain abscesses, skin and soft-tissue infections, and pneumonia
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Fig. 9 Immune response against staphylococcal bone infection.
Blood samples were collected after each infection period (on days 4,
8 and 15) and were processed to obtain serum. Quantitative
measurements of IL-1 (a), IL-17 (b), and IL-6 (c) were performed. All
values were analyzed using one-way ANOVA followed by a post-hoc
Tukey test. Error bars indicate standard errors of the means. A Pvalue of < 0.05 was considered statistically significant
(**p-value < 0.01)

[45, 82, 83]. Loughran et al. [73] studied acute, posttraumatic OM using a murine model and compared the extent of virulence in two clinical isolates of staphylococcal
strains (USA300 LAC and USA200 UAMS-1). They
found that the USA300 LAC strain showed increased
virulence and bone damage compared with the UAMS-1
strain, although the difference was not statistically significant. They also found increased osteolysis by a CAMRSA strain of S. aureus (USA300 LAC), which was
partly due to its ability to express high levels of
accessory gene regulator (agr), resulting in the production of high levels of extracellular toxins, such as phenol-soluble modulins (PSMs) and alpha toxins, which
were shown to be more cytotoxic to osteoblasts in vitro.
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In this study we showed that several staphylococcal proteins that facilitates S. aureus to attach bone extracellular matrix components, infect bone osteoblasts, and
modulates host immune system were significantly affected in the msaABCR mutant (Table 2). Several
staphylococcal virulence factors that are cytotoxic to osteoblasts, triggers osteoclastogenesis, and induces bone
loss and/or destruction are also affected in the
msaABCR mutant (Table 2). Several previous studies
have linked increased protease production with defective
biofilm formation, reduced accumulation of secreted
virulence factors, reduced toxicity to osteoblasts and osteoclasts cells in vitro, and reduced virulence and attenuation in OM infection [31, 46, 51–53, 73, 84]. Cassat et
al. 2013 [46] showed that extracellular-secreted proteases, mainly aureolysin (Aur), significantly reduced the
abundance of staphylococcal exoproteomes that are important for host-tissue binding, biofilm formation, invasion of host cells, and the cytolytic factors that trigger
cortical bone destruction. Increased extracellular proteases (SspA, SspB, SspC, and Aur) that leads to increased
cell death and defective biofilm formation was one of
the major phenotypes of msaABCR mutant [31, 32]. In
this study, msaABCR whole cell proteomics analysis also
showed significant production of SspA, SspB, SspC, Aur,
and staphopain A. A study by Rom JS et al., [84] showed
reduced accumulation of alpha toxin (Hla) and extracellular protein A in the msaABCR mutant [84]. They also
showed that deletion of msaABCR leads to the significant decrease in accumulation of extracellular proteins
[84]. Findings from this study and study by Rom JS et
al., [84] suggest that decreased pathogenicity and/or decreased bone destruction by the msaABCR mutant may
be mainly due to increased proteases production and/or
activity, thus affecting the abundance of extracellular
proteins required for host-tissue binding (cell adhesion
factors), hosts cells invasion, evasion of immune system,
and osteolytic factors such as LukA and alpha hemolysins that have been shown to play role in osteomyelitis
in previous studies [20, 46, 48, 54–56]. However, the
msaABCR proteomics were performed in in vitro conditions and not from in-vivo samples. Therefore, additional studies are needed to further define the
contribution of various msaABCR-regulated molecules
to pathogenesis during osteomyelitis infection.

Conclusions
In this study we showed that the msaABCR mutant is
defective in several cell-surface adhesion protein factors
that are important for interacting with and colonizing
host cells, such as osteoblasts, and host cell matrix, including bone extracellular matrix. In addition, the
msaABCR mutant is also defective in some important
virulence factors, such as hemolysin and leukocidins,
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Fig. 10 Alkaline phosphatase (ALP) activity measurements in serum. Alkaline phosphatase activity in serum was measured after each infection
period (on days 4, 8, and 15) as an indicator of bone metabolic activity. All values were analyzed using one-way ANOVA followed by a post-hoc
Tukey test. Error bars indicate standard errors of the means. A P-value of < 0.05 was considered statistically significant (**p-value < 0.01)

which can kill host cells, such as osteoblasts, and their
dissemination that can lead to infection progression.
Thus, the msaABCR operon mutant is defective in
implant-associated in vivo biofilm formation on K-wires,
and decreased intraosseous survivability, that led to reduced bone damage and therefore it plays a role in
implant-associated chronic OM in rat model. The findings from this study provide additional insights into the
pathogenesis of implant-associated chronic OM infections by USA300 LAC and explore the potential for targeting msaABCR for therapy. It should be however
noted that while we observed reactive bone formation in
the msaABCR mutant similarly to the sham controls, the
msaABCR mutant still caused some degree of bone destruction. This implicates other virulence factors, whose
production were not impacted by the deletion of
msaABCR operon and should be investigated further to
fully understand osteomyelitis pathogenesis caused by S.
aureus.

Methods
Bacterial strains and growth media

Overnight bacterial cultures (the USA300 LAC strain, the
msaABCR operon deletion mutant (msaABCR mutant)
strain [32], and a complementation strain [32] were prepared by inoculating cells from frozen culture stocks into
culture tubes containing 5 mL of freshly prepared tryptic
soy broth (TSB) and incubating at 37 °C with continuous
shaking at 225 rpm. The overnight cultures were diluted 1:
10 in fresh medium (TSB or biofilm medium: TSB supplemented with 3% sodium chloride and 0.5% glucose) and

incubated for 2 h to prepare a starter culture for further experiments. The starter culture was normalized to an
optical density at 600 nm (OD600) of 0.05 (2X107
CFUs per ml) in prewarmed TSB for planktonic
growth conditions and in prewarmed biofilm media
for biofilm growth conditions.
Sprague Dawley rats and experimental design

This study included 96 animals randomly divided using
a random number generator into 4 groups (n = 24)
USA300 LAC, msaABCR mutant, complementation, and
sham. All animals underwent a surgical procedure to
place a K-wire with or without bacteria, and three animals per group were sacrificed immediately following
the surgical procedure to assess bacterial load. The
remaining 21 animals per group (7 animals per time
point based upon power analysis) were euthanized on
days 4, 8, and 15 by an overdose of 5% isoflurane (2chloro-2-(difluoromethoxy)-1,1,1-trifluoro-ethane)
followed by bilateral pneumothorax prior to collection
of blood, vital organs, and bone. Post-mortem blood
samples were processed to obtain plasma and serum, aliquoted into storage tubes, and stored at − 80 °C. Five
legs were placed on ice and processed for bacterial
counts, while 2 legs were processed for microCT analysis
of bone followed by histopathological analysis. Vital organs (heart, spleen, kidneys, and lungs) were collected
and immediately frozen at − 80 °C for analysis of bacterial load resulting from dissemination from the infection
site. Organ samples for histopathological studies were
placed in buffered formalin.
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Table 2 Proteins involved in progression and pathogenicity of staphylococcal osteomyelitis infection
Proteins that interacts with bone matrix and osteoblasts cells
MSCRAMM(s)

Functional response

Mean peptide spectral count

References

Planktonic condition

Biofilm condition

USA300
LAC

msaABCR
mutant

USA300
LAC

msaABCR
mutant

Fibronectin binding protein A (FnbA)

Internalization

2

0

81

128

[42, 43]

Fibronectin binding protein B (FnbB)

Internalization

–

–

0

11*

[42, 43]

Serine-aspartate repeat-containing
proteins (SdrC)

Colonization

0

8*

–

–

[43]

Serine-aspartate repeat-containing
proteins (SdrD)

Colonization

36

12*

0

2

[43]

Extracellular matrix binding protein
(Embp)

Colonization

7

2*

0

3*

[44]

Toxins and exoproteins involved in osteoblast cytotoxicity and induce osteoclastogenesis
Toxins / exoproteins
Alpha hemolysin (Hla)

Osteoblast/osteoclast cell death

19

6*

–

–

[45, 46]

Panton-Valentine leucocidin (PVL)

Persistence of infection

37

24

203

308

[20, 21, 47,
48]

Uncharacterized leukocidin-like protein Osteoblast cytotoxicity
1 (LukL1)

215

83*

232

332

[20, 48]

Staphylococcal protein A (SpA)

–

–

12

5*

[47, 49, 50]

[46, 51–53]

Induction of bone loss (apoptosis)
and bone destruction
(osteoclastogenesis), inhibits
mineralization

Other virulence factors that plays role in osteomyelitis infection and immune evasion
Virulence factors
0

38*

–

–

Cysteine protease (SspB)

12

66*

–

–

Cysteine protease (SspC)

0

12*

7

22*

Serine protease (sspA)

modulates secreted osteolytic factors

0

60*

–

–

Staphopain A

immunomodulatory protein that
blocks neutrophil recruitment

37

31

0

5*

[54]

Map protein

Immunomodulators interfering T cell 85
mediated response

0*

116

0*

[55]

Immunoglobulin-binding protein sbi

Immune evasion factor

46

19*

98

114

[56]

Clumping factor A (ClfA)

Unknown

11

6

16

5*

[57]

Clumping factor B (ClfB)

Unknown

9

3*

33

44

[57]

Aureolysin (Aur)

Proteins differentially expressed ≥2-fold is considered significant (*) and is shown in bold

An implant-associated OM model using the Sprague
Dawley rat (SD-rat)

The surgical procedure was performed as previously described for an animal model of chronic OM, with slight
modifications [39, 40]. In brief, the sterile K-wires (0.035″
× 7″ TROCAR-TROCAR, Jorgensen Laboratories Inc.,
Loveland, CO) were aseptically cut in half (0.035″ × 3.5″)
and coated with SD-RAT plasma overnight at 4 °C to facilitate colonization with S. aureus cells. Biofilm formation
on the K-wires was initiated by incubating them at 37 °C
for 24 h with the test strains (USA300 LAC, msaABCR
mutant, and complementation) pre-normalized to an
OD600 of 0.05 (2X107 CFUs per ml). The biofilm-coated

K-wires were stored at − 80 °C until use and for not more
than 7 days. Six biofilm-coated K-wires were used to enumerate the bacterial CFUs prior to the surgical procedure
to evaluate the number of initial bacterial CFUs. Sterile Kwires coated with SD-Rat plasma were used as negative
control (sham infection). The K-wires colonized with test
strains were inserted into the bones of Sprague Dawley
rats (SD-Rat) to induce OM.
Following approval from the University of Mississippi
Medical Center institutional Animal Care and Use Committee (IACUC), a total of 96 SD-rats weighing 250–300 g
were purchased from Charles River Labs. The animals were
housed under a 12-h day/night light cycle and allowed
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access to food and water ad libitum. The animals were acclimated for 1 week prior to surgical manipulation. The animals were randomly divided using a random number
generator into into 3 sets of 4 groups (n = 24), and a K-wire
was inserted surgically. Isoflurane (2%) was used for
anesthesia induction followed by intraperitoneal injection
of ketamine (75 mg/kg) and xylazine (5 mg/kg) for surgical
anesthesia, and a presurgical dose of Buprenorphine (Temgesic, Schering-Plough, Brussels, Belgium) (0.05 mg/Kg) for
analgesia. The skin above the bone was disinfected using
70% ethanol, providone iodine scrub, providone, followed
by 70% ethanol. Following the aseptic surgical preparation,
the position of the bone metaphysis was determined by palpation, and the K-wire pin was implanted transcortically
through the metaphysis. Afterwards, the pin was bent on
both ends and cut adjacent to the skin to secure it in the
bone. Six hours post-surgery, the animals received a second
subcutaneous injection of 0.10 mg/kg buprenorphine (Temgesic, Schering-Plough, Brussels, Belgium). Following surgery, the animals were housed individually for the first 3
days post-surgery, provided Buprenorphine (0.1 mg/kg) for
pain every 12 h during the first 2 days and then assessed for
pain daily, and analgesics were provided as needed.
Wounds were evaluated for infection daily for the duration
of the experiment. Animal cages were cleaned daily for the
first 3 days, then every other day for the remainder of the
experiment. The bedding was collected into biohazard bags,
and the cages disinfected before entering the cage wash
area.
Bacterial counts

To determine the number of bacterial inoculums or
colony-forming units (CFUs) prior to infection, the K
wires coated with each bacterial strain (3 animals per
group) were inserted in rat bone. All the animals were
euthanized immediately, and K-wires and bone samples
were harvested to enumerate the bacterial CFUs retained
in the bone and on the K-wires after surgery.
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1x PBS and sonicated for 30 min in a 2.8-L ultrasonic
bath (Fischer Scientific) to release the bacteria from the
biofilms that had formed on the pins. Appropriate serial
dilutions were performed and plated on TSA media to
count the total number of bacterial CFUs present on the
K-wire samples.
Blood samples

The blood samples were collected from all animals for
enumeration of bacterial CFUs (7 animals per group).
One hundred microliters of blood samples were serially
diluted in 1 ml of 1X PBS and plated on TSA media to
count the total number of bacterial CFUs present in the
blood samples after overnight incubation at 37 °C.
Organ samples

Six organ samples per group (heart, spleen, liver, kidney,
and lung) were collected in a sterile plastic container
and immediately stored at –80 °C until use. They were
later retrieved from the − 80 °C freezer and rinsed with
sterile 1x PBS thrice. The organ samples were cut into
small pieces using a sterile surgical blade and transferred
to a 15-ml FastPrep tube containing 5 ml of an equal
mixture of 0.5-mm and 1-mm zirconia/silica beads
(BioSpec Products). Five milliliters of sterile 1x PBS was
added, and the beads beating was performed in
FastPrep-24 instrument (4 times, with a setting of 6.5 M/
S for 60 s and 2 min off time on ice). The cell debris was
removed by a quick spin at 2000 x g for 2 min, and the
supernatant was transferred to another 15-ml tube. The
samples were serially diluted and plated on TSA media
to count the total number of bacterial CFUs present in
the organ samples after overnight incubation at 37 °C.
Micro-computed tomography (microCT) analysis of
infected bone

Infected bone samples (5 per group) with K-wire pins
were carefully excised from the bone, and the bone shaft
was removed using a scalpel. The bone was cut into
smaller sections, homogenized in the presence of liquid
nitrogen using mortar and pestle. The samples were suspended in 5 ml of 1X PBS, and plated in tryptic soy agar
(TSA) agar plates after serial dilutions in sterile 1x PBS
to determine the viable bacterial count, as previously described [39].

High-resolution analysis of cortical thickness, cortical
bone destruction, and underlying trabecular bone in the
sham group and the bacteria-treated groups was determined by microCT imaging using a 1172 μCT SkyScan
scanner with a 10-megapixel camera (Skyscan, Aartselaar, Belgium) and the manufacturer’s analytical software. The SkyScan scanning parameters were set up as
previously described by Tucci et al. [85]. Structural indices were calculated using CTAn software (Skyscan, Aartselaar, Belgium) and BoneJ software [86]. Differences in
cortical bone destruction were analyzed using one-way
ANOVA followed by a post-hoc Tukey test. A P-value
of < 0.05 was considered statistically significant.

K-wire samples

Histopathological analysis of infected bone

The K-wires (5 per group) were carefully removed from
the infected bone samples and rinsed twice with sterile
1x PBS. The K-wires were suspended in 5 ml of sterile

For histopathological analysis, samples of the proximal
half of the bone were fixed in neutral-buffered formalin
solution, decalcified using Cal-Ex™ solution, embedded

Bone samples
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in OCT for frozen sectioning, and cut into 10-μm sections. The sections were stained with hematoxylin and
eosin (H & E). Histopathological scores were determined
for intraosseous acute inflammation (IAI), intraosseous
chronic inflammation (ICI), periosteal inflammation (PI),
and bone necrosis (BN) using the system previously described by Smeltzer et al. [41]. Each parameter was
scored on a 5-point scale (0–4), and the scores for each
section were added together to provide a total histopathological score, as shown in Table 1.
ELISA testing for IL-6, IL-1, and IL-17

Commercially available colorimetric sandwich enzymelinked immunosorbent (ELISA) assays were used to obtain quantitative measurements of IL-1, IL-17, and IL-6
(R&D Systems). The manufacturer’s protocols were
followed to determine the concentrations of cytokines in
the sample. Briefly, either 25 μL of standard or plasma
sample was dispensed in duplicate into microtiter plate
wells coated with IL-6, IL-17, or IL-1. The plate was incubated for 2 h to allow the cytokine present in the sample or standard to bind to the immobilized antibody.
The plates were washed with 100 μL of the wash buffer
supplied by the manufacturer three times, and then
25 μL of a second biotinylated cytokine antibody was
added and the plate incubated overnight at 4 °C. Following the overnight incubation, the plate was washed three
additional times with 100 μL of wash buffer per wash.
After washing, the unbound biotinylated antibody, which
was conjugated to HRP with streptavidin, was pipetted
into the wells, and incubated for 1 h. The wells were
washed again in a similar manner, and 50 μL of TMB
substrate solution were added to the wells for 20 min
followed by the addition of 50 μL of stop solution. The
intensity of the color in the samples was compared with
a standard curve generated by the color intensity of the
concentration standards at 405 nm, and the amount of
cytokine in the samples was thereby determined.
Alkaline phosphatase (ALP) assay

The activity of ALP in serum was determined by measuring the rate of hydrolysis of various phosphate esters
under specified conditions. In the Pointe Scientific (Canton, MI) kinetic assay, p-nitrophenyl phosphate is hydrolyzed to p-nitrophenol and inorganic phosphate and
detected at 405 nm, and the rate of hydrolysis is directly
proportional to ALP activity. Working reagents were
prepared according to the manual instructions. One
milliliter of reagent was pipetted into a spectrophotometer cuvette and warmed to 37 °C for 5 min. The reference cuvette contained water and was used as the blank.
A plasma aliquot of 0.25 mL was added to warm reagent
and allowed to incubate at 37 °C for an additional minute. The absorbance was determined at 405 nm, and
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the cuvette was then placed back in the 37 °C heat block
and measured again after 5 and 10 min. The average absorbance difference per minute was calculated and
multiplied by a factor of 2187 to convert the results to
IU/L.
Proteomics: analysis of the Staphylococcus aureus
proteome using a label-free strategy

For whole cell proteomics analysis, the cells were grown
to OD600 of 1.5 in TSB broth for planktonic growth
condition. The cells were collected, washed twice with
ice cold 1X PBS and were used for whole cell proteomics
analysis. For biofilm growth condition, the biofilm was
grown in flow cells (Stovall Life Science, Greensboro,
NC). The flow cells were pre-coated with human plasma.
One hundred microliter of starter bacterial suspension
were inoculated into the flow cells by injection and
allowed to incubate at 37 °C for 1 h. Biofilm media was
then pumped through the flow cells at a flow rate of 0.5
ml/min for 24 h. The biofilm cells were collected,
washed twice with ice cold 1X PBS and were used for
whole cell proteomics analysis.
Trypsin digestion

Protein extraction was performed using urea buffer (8 M
urea, 150 mM NaCl, 50 mM Tris-HCl, pH 8) and mechanical disruption with 1.0-mm silica beads in a Bullet
Blender (Next Advance). Samples were centrifuged at
10,000 x g for 10 min and the supernatant removed. The
protein concentration was determined using a Qubit
fluorometry assay (Invitrogen). Protein concentrations
were normalized with lysis buffer. Five hundred micrograms of protein from each sample was reduced with 10
mM dithiothretiol for 30 min at room temperature and
alkylated with 10 mM iodoacetamide for 45 min at room
temperature. Trypsin was added at a 1:30 enzyme-tosubstrate ratio, and urea was diluted to 1.6 M with 25
mM ammonium bicarbonate. The reaction was terminated with 0.1% trifluoroacetic acid (TFA) and the suspension clarified by centrifugation at 10,000 x g for 10
min.
Solid-phase extraction (SPE)

Cleared peptide solution was processed by SPE on a Waters HLB PRiME with 30-mg-capacity cartridges using 5
psi. In brief, samples were loaded directly onto the cartridge per the vendor protocol and washed with 2 × 1 mL
of 0.1% TFA. Peptides were eluted with 2 × 500 μL of
90% acetonitrile with 0.1% TFA, and the peptide concentrations were determined by UV absorbance at 280 nm.
Mass spectrometry

Two micrograms of each sample were analyzed by nanoLC-MS/MS (MSBioworks, Ann Arbor, MI, USA) with a
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Waters NanoAcquity HPLC system interfaced to a ThermoFisher Q Exactive mass spectometer using a 4-h
reverse-phase gradient. Peptides (30 μL) were loaded on
a trapping column and eluted over a 75-μm analytical
column at 350 nL/min, and both columns were packed
with Jupiter Proteo resin (Phenomenex, Torrance, CA,
USA). The mass spectrometer was operated, and the
data was obtained in data dependent mode with the
Orbitrap operating settings as previously described by
Franco M et al. [87].
Data processing

A composite database comprising the 20 sequenced S.
aureus strains was created. The strains were 04–02981,
bovine RF122 (ET3–1), COL, ED98, JH1, JH9, JKD6159,
MRSA ST398 (isolate S0385), MRSA252, MSSA476,
Mu3 (ATCC 700698), Mu50 (ATCC 700699), MW2,
N315, NCTC 8325, Newman, TW20 (0582), USA300
(TCH1516), and ED133. Data were analyzed using Mascot software with the parameter settings as previously
described by Franco M et al. [87]. Mascot DAT files
were parsed for processing with Scaffold software for
validation, filtering, and to create a nonredundant list
per sample. Data were filtered using a 1% protein and
peptide false discovery rate (FDR) and required at least
one unique peptide per protein.
Comparative gene ontology analysis of proteomics data

As a part of the functional genomic analysis of our
whole-cell proteomics data, we performed gene ontology
(GO) classification of differentially expressed (≥3-fold)
proteins, as previously described [33]. We used a freely
available web-based GO analysis tool (Comparative GO,
[88, 89]) to better understand the differentially expressed
proteins in terms of the biological pathways involved.
Statistical analysis

All statistical analyses to test for significance in this
study were done using OriginPro software (Originlab,
Northampton, MA). A significance level of 0.05 was set
as the cutoff value while performing statistical analyses.
All the data obtained from CFU experiments were analyzed using one-way ANOVA followed by a post-hoc
Tukey test.

Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12866-020-01964-8.
Additional file 1: Fig. S1. Microbial counts from vital organ samples to
study staphylococcal dissemination. The organ samples (n = 6): liver (a),
kidney (b), and lung (c) from sham and infected animals were harvested
after each infection period (on days 4, 8, and 15) and were processed to
enumerate the bacterial CFUs, as described in methods. The difference in
microbial count between the USA300 LAC and msaABCR mutant strains
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was analyzed using one-way ANOVA followed by a post-hoc Tukey test.
Error bars indicate standard errors of the means. A P-value of < 0.05 was
considered statistically significant.
Additional file 2: Fig. S2. Structural indices of sham and infected
bones after day 4 post-infection. Analysis of bone trabecular microarchitecture (percentage bone volume, BV/TV; bone surface/volume ratio, BS/
BV; trabecular pattern factor, Tb.Pf; trabecular thickness, Tb.Th; trabecular
spacing, Tb.Sp; and trabecular number, Tb.N) were performed using Nrecon and BoneJ software. All values were analyzed using one-way ANOVA
followed by a post-hoc Tukey test. Error bars indicate standard errors of
the means. A P-value of < 0.05 was considered statistically significant
(**p-value < 0.01).
Additional file 3: Fig. S3. Structural indices of sham and infected
bones after day 8 post-infection. Analysis of trabecular bone microarchitecture (percentage bone volume, BV/TV; bone surface/volume ratio, BS/
BV; trabecular pattern factor, Tb.Pf; trabecular thickness, Tb.Th; trabecular
spacing, Tb.Sp; and trabecular number, Tb.N) were performed Nrecon
and BoneJ software. All values were analyzed using one-way ANOVA
followed by a post-hoc Tukey test. Error bars indicate standard errors of
the means. A P-value of < 0.05 was considered statistically significant
(**p-value < 0.01).
Additional file 4: Table S1. Comparative Gene Enrichment analysis of
msaABCR proteomics under planktonic conditions.
Additional file 5: Table S2. Comparative gene enrichment analysis of
msaABCR proteomes under biofilm growth condition.
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